Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

157 results
Display

Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?

Iavazzo C, Gkegkes ID

This study aimed to discuss the possible role of morcellation for a giant myoma in the minimal invasive approach. Current literature, including U.S. Food and Drug Administration guidelines, was reviewed....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Largest Uterine Leiomyoma Removed by RoboticAssisted Laparoscopy in the Late Reproductive Age: A Case Report

Jeong HG, Lee MJ, Lee JR, Jee BC, Kim SK

Uterine leiomyoma is a very common gynecological tumor in the reproductive years. Recent studies have shown that surgical treatment of uterine leiomyoma using robotic-assisted laparoscopic myomectomy (RALM) is associated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances in Uterine Myoma and Pregnancy

Lee SJ, Hwang JY

Uterine myomas (fibroids) are the most common benign tumors in women and occur in 20%–40% of women of reproductive age. Myomas are benign monoclonal tumors that develop from the smooth...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison between transumbilical and transvaginal morcellation of a large uterus during single-port-access total laparoscopic hysterectomy

Oh SJ, Lee SY, Kim WY, Kang J, Han KH, Lee SH, Park JS

Objective To compare the perioperative outcomes of transumbilical morcellation (TUM) and transvaginal morcellation (TVM) of a large uterus (≥500 g) during single-port-access total laparoscopic hysterectomy (SPA-TLH). Methods A total of 57 patients who underwent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term outcomes of single-port laparoscopic myomectomy using a modified suture technique

Kang M, Kim J, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH

OBJECTIVE: To evaluate the long-term outcomes, including the pregnancy outcome and recurrence rate after single-port laparoscopic myomectomy (LM) using a modified suture technique with a Hem-o-lok clip (Choi's LM) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Deep Burn Injuries on the Lower Abdomen after HIFU Treatment for Uterine Myoma

Yu SH, Kim DC

High-intensity focused ultrasound (HIFU) has been regarded as a non-invasive uterine-preserving treatment for women with uterine myoma. Numerous studies have reported that it is a relatively safe and effective treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prior uterine myoma and risk of ovarian cancer: a population-based case-control study

Tseng JJ, Huang CC, Chiang HY, Chen YH, Lin CH

OBJECTIVE: Uterine myoma which results in the magnitude of ovarian cancer remains uncertain. This study aimed to assess the association between women with previous uterine myoma and the risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics Indicating Uterine Leiomyoma, Adenomyosis, and Uterine Leiomyoma Coexisting with Adenomyosis: Retrospective Study

Hong JA, Chung SH

OBJECTIVE: This study is to compare the baseline characteristics and symptoms between groups with leiomyoma only (group M; myoma group), adenomyosis only (group A; adenomyosis group), and leiomyoma and adenomyosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hysteroscopic myomectomy without anesthesia

Rodríguez-Mias NL, Cubo-Abert M, Gomila-Villalonga L, Gómez-Cabeza J, Poza-Barrasús JL, Gil-Moreno A

OBJECTIVE: Scarce literature about myoma removal without anesthesia has been published. The aim of this paper is to evaluate the feasibility of a new alternative for a hysteroscopic myomectomy in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lack of Haptic Feedback Is Replaced by More Developed Visual Sense during Robotic Myomectomy

Moon HS, Cho E, Yoo HK

In the reproductive age, many women have several uterine myomas and present with abnormal uterine bleeding, dysmenorrhea, and occasionally infertility. There are three surgical approaches to perform myomectomy, including robotic-assisted,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Huge uterine myoma as a cause of thromboemobolic stroke

Lee HJ, Shin DH

BACKGROUND: Embolic stroke undetermined source (ESUS), which is defined as nonlacunar infarction in the absence of cardioembolic sources, proximal artery stenosis excluded by echocardiogram, holter monitoring and vascular images, is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Gait Disturbance Resolved with Hysterectomy in a Woman

Chung SH

Uterine leiomyoma is the most common benign tumors in females and varies widely in size. Lumbosacral plexopathy is a rare disorder characterized by a sudden onset of leg paresthesia, muscle...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sonographic and Clinical Characteristics of Uterine Sarcoma Initially Misdiagnosed as Uterine Fibroid in Women in the Late Reproductive Age

Kim JH, Kim HJ, Kim SH, Shin SA, Park SY, Kim DY, Lee SR, Chae HD, Kang BM

OBJECTIVES: Uterine sarcoma is a rare malignant tumor, which is usually diagnosed in postmenopausal women. These sarcomas are occasionally misdiagnosed as uterine fibroids, thereby leading to delayed diagnosis in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report

Lee M, Kim TH, Kim SJ, Jee BC

Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incarceration of early gravid uterus with adenomyosis and myoma: report of two patients managed with uterine reduction

Kim HS, Park JE, Kim SY, Kim JE, Chae SH, Sohn IS, Hwang HS, Kwon HS

Although gravid uterine incarceration is typically diagnosed during the early second trimester, we encountered two unusual cases in early pregnancy. A 34-year-old multiparous woman with adenomyosis presented at 7 +...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas

Kim YN, Eoh KJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT

OBJECTIVE: Intravenous leiomyomatosis (IVL) and benign metastasizing leiomyoma (BML) are uncommon variants of benign uterine leiomyomas with extrauterine manifestations. Categorizing the extent of disease allows clinicians to delineate the clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study

Moradan S

OBJECTIVES: There are many drugs for of symptomatic fibroids. Gonadotropin-releasing hormone (GnRH) agonists are the well known drugs. Also, aromatase inhibitors are effective. All published studies surveyed the effect of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Spontaneous Uterine Rupture after Uterine Artery Embolization for the Treatment of Uterine Myomas

Kim SJ, Kim AM, Kim TY, Kim JW, Kim YH

As intervention techniques have been developed recently, minimal invasive treatment for uterine myoma using uterine artery embolization is receiving attention increasingly. Uterine rupture occurs rarely, but once it occurs, it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is robot-assisted laparoscopic myomectomy limited in multiple myomas?: a feasibility for ten or more myomas

Kim H, Shim S, Hwang Y, Kim M, Hwang H, Chung Y, Cho HH, Kim MR

OBJECTIVE: To evaluate the feasibility of robot-assisted laparoscopic myomectomy in multiple myomas over 10. METHODS: A retrospective study was conducted for 662 patients who underwent robot-assisted laparoscopic myomectomy and open myomectomy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis

Kim SY, Moon HM, Lee MK, Chung YJ, Song JY, Cho HH, Kim MR, Kim JH

OBJECTIVE: We compared the expression levels of Müllerian inhibiting substance (MIS)/anti-Müllerian hormone type II receptor (AMHRII) in uterine myoma and adenomyosis to evaluate the possibility of using MIS/anti-Müllerian hormone (AMH)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr